Fatima Cardoso Selected Research

Fatima Cardoso Research Topics

Disease

92	Breast Neoplasms (Breast Cancer) 10/2022 - 07/2002
35	Neoplasms (Cancer) 10/2022 - 07/2002
8	Neoplasm Metastasis (Metastasis) 04/2022 - 05/2007
4	Fatigue 10/2022 - 03/2011
4	Disease Progression 04/2021 - 01/2018
2	Triple Negative Breast Neoplasms 10/2022 - 01/2020
2	Neutropenia 10/2022 - 03/2011
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017 - 02/2016
2	Exanthema (Rash) 10/2014 - 08/2005
1	Mouth Neoplasms (Oral Cancer) 10/2022
1	COVID-19 08/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Bone Diseases (Bone Disease) 01/2019
1	Pain (Aches) 01/2018
1	Heart Failure 01/2018
1	Heart Arrest (Cardiac Arrest) 01/2018
1	Sudden Death 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 01/2018
1	Infections 01/2018
1	Frailty 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Male Breast Neoplasms (Male Breast Cancer) 01/2017
1	Hypersensitivity (Allergy) 01/2016

Drug/Important Bio-Agent (IBA)

16	Trastuzumab (Herceptin)FDA Link 01/2022 - 10/2002
12	Estrogen ReceptorsIBA 01/2022 - 12/2004
10	Hormones (Hormone)IBA 10/2022 - 12/2009
9	Pharmaceutical PreparationsIBA 02/2017 - 06/2004
8	Tamoxifen FDA LinkGeneric 01/2020 - 12/2004
7	Docetaxel (Taxotere)FDA Link 10/2020 - 07/2002
6	AnthracyclinesIBA 10/2022 - 02/2006
6	ErbB Receptors (EGF Receptor)IBA 10/2022 - 12/2005
6	human ERBB2 proteinIBA 01/2021 - 02/2006
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2002
5	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 07/2002
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 07/2002
4	Letrozole (Femara)FDA LinkGeneric 04/2022 - 01/2008
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 04/2011
4	Progesterone Receptors (Progesterone Receptor)IBA 02/2021 - 12/2004
4	Monoclonal AntibodiesIBA 02/2017 - 12/2005
4	ParaffinIBA 12/2008 - 07/2002
3	taxaneIBA 10/2022 - 02/2008
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 12/2011
3	Epirubicin (Ellence)FDA LinkGeneric 10/2022 - 04/2011
3	Aromatase InhibitorsIBA 01/2020 - 02/2006
3	Everolimus FDA Link 01/2018 - 01/2008
3	eribulin FDA Link 01/2016 - 03/2011
3	Lapatinib (GW572016)FDA Link 10/2014 - 03/2008
3	Biological ProductsIBA 07/2013 - 01/2007
3	Sunitinib (Sutent)FDA Link 12/2012 - 08/2009
3	Taxoids (Taxanes)IBA 11/2008 - 02/2006
2	pembrolizumabIBA 10/2022 - 01/2020
2	Carboplatin (JM8)FDA LinkGeneric 10/2022 - 01/2020
2	ribociclibIBA 04/2022 - 03/2022
2	pertuzumabIBA 01/2022 - 01/2018
2	TOR Serine-Threonine KinasesIBA 01/2018 - 08/2005
2	Tumor Biomarkers (Tumor Markers)IBA 02/2016 - 04/2008
2	Methotrexate (Mexate)FDA LinkGeneric 05/2015 - 07/2002
2	Fluorouracil (Carac)FDA LinkGeneric 05/2015 - 07/2002
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 04/2011 - 10/2004
2	Formaldehyde (Formol)FDA Link 12/2008 - 07/2008
2	TubulinIBA 07/2008 - 12/2002
2	tau Proteins (tau Protein)IBA 07/2008 - 12/2002
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2008 - 03/2007
2	Bortezomib (Velcade)FDA Link 12/2006 - 06/2004
1	palbociclibIBA 10/2022
1	thiamine triphosphorate (TTP)IBA 04/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	CarbonIBA 04/2021
1	margetuximabIBA 04/2021
1	EndocineIBA 02/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2021
1	Capecitabine (Xeloda)FDA Link 10/2020
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	TESIBA 01/2020
1	Excipients (Suspending Agents)IBA 01/2019
1	Biosimilar PharmaceuticalsIBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	exemestane (Aromasin)FDA Link 01/2018
1	Ado-Trastuzumab EmtansineIBA 01/2018
1	Bevacizumab (Avastin)FDA Link 02/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2017
1	Phenobarbital (Luminal)FDA Link 01/2017
1	Messenger RNA (mRNA)IBA 02/2016

Therapy/Procedure

44	Therapeutics 10/2022 - 07/2002
20	Drug Therapy (Chemotherapy) 10/2022 - 12/2002
12	Adjuvant Chemotherapy 10/2020 - 10/2006
4	Radiotherapy 02/2021 - 11/2008
3	Immunotherapy 01/2019 - 01/2016
2	Neoadjuvant Therapy 10/2022 - 01/2020
2	Mastectomy (Mammectomy) 01/2022 - 02/2021
1	Tattooing 04/2021
1	Intravenous Administration 02/2021
1	Ambulatory Care (Outpatient Care) 02/2021
1	Operative Surgical Procedures 08/2020
1	Segmental Mastectomy (Lumpectomy) 01/2020
1	Contraindications 01/2020
1	Secondary Prevention 01/2019
1	Aftercare (After-Treatment) 03/2015
1	Terminal Care (Care, Terminal) 03/2015